P
PhaseV
Biotech & Life Sciences · Tel Aviv-Yafo, Israel · Founded 2023
Uses advanced algorithms to optimize clinical trials, improving success rates, efficiency, and uncovering hidden signals in the data MoreLess
PhaseVTrials.com is a cutting-edge startup that specializes in developing a platform for adaptive clinical trial design and execution. The company leverages advanced technologies such as reinforcement learning and causal machine learning (ML) to optimize clinical decisions at any stage of the trial process. Their platform features an intuitive user interface and a flexible software architecture, making it accessible and adaptable for various clinical needs.
PhaseVTrials primarily serves pharmaceutical companies, biotech firms, and research institutions that are involved in drug development and clinical research. The market it operates in is the clinical trials sector, which is a critical component of the broader healthcare and pharmaceutical industries.
The business model of PhaseVTrials revolves around providing a software-as-a-service (SaaS) platform. Clients subscribe to their platform to design, manage, and execute clinical trials more efficiently. The company generates revenue through subscription fees, which can be tiered based on the level of service and features required by the client. Additionally, they may offer consulting services to help clients optimize their trial designs and execution strategies.
PhaseVTrials stands out in the market by offering a unique combination of advanced algorithms and user-friendly software. This allows clients to make data-driven decisions, potentially reducing the time and cost associated with bringing new drugs to market. The platform's ability to adapt and provide real-time insights is particularly valuable in the fast-paced and highly regulated environment of clinical trials.
In summary, PhaseVTrials.com is revolutionizing the clinical trial process with its adaptive design and execution platform, serving pharmaceutical and biotech companies with a SaaS business model that leverages advanced algorithms for optimal decision-making.
Keywords: adaptive clinical trials, reinforcement learning, causal ML, SaaS, pharmaceutical, biotech, drug development, user interface, software architecture, data-driven decisions.
Company overview
PhaseV company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2023
- Headquarters
- Tel Aviv-Yafo, Israel
- Employees
- 63
- Open positions
- 7
- Dealroom signal
- 92.9
Valuation & funding
PhaseV funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | May 2025 | $50M | $200M | LionBird · Exor Ventures · Insight Partners · Viola Ventures | ↗ |
| EARLY VCOther financing | Oct 2023 | $15M | $60M | LionBird · Viola Ventures · Exor Ventures | ↗ |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $1.1M | 0% | 63 |
| 2025 | $1.1M | 0% | 51 |
| 2024 | $1.1M | 0% | 28 |
| 2023 | $1.1M | — | 15 |
Growth signals
PhaseV website traffic
Latest recorded traffic for PhaseV is 7.9K monthly website visits, down 28.2% over the last three months. PhaseV's team grew 23.5% over the past year.
Hiring
Open positions at PhaseV
Current openings linked to this company in Dealroom.
Comparisons
PhaseV compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
PhaseV's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where PhaseV has talent and traffic
team presence
In the news
Latest news about PhaseV
Recent press, funding announcements, and product moves mentioning PhaseV — open to read from the original sources.
Market sentiment
What the market is saying about PhaseV
An AI-synthesized read of the highest-engagement posts about PhaseV on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See PhaseV’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.












